Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Politico, in “Burgess Is Reworking His Interoperability Bill—Privacy Advocates Speak Out—Docs Attack 21st Century Bill.”
Following is an excerpt:
FDA has rarely directed letters at software vendors; Epstein Becker Green lawyer Bradley Merrill Thompson recalls “only a few” such warnings.
